Sep 14, 2017 • 8:00 am EDT Corbus Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
Aug 31, 2017 • 8:05 am EDT Corbus Pharmaceuticals to Host Fireside Chat on Dermatomyositis with Expert Physician and Researcher, Victoria Werth, MD
Aug 9, 2017 • 7:05 am EDT Corbus Pharmaceuticals Reports 2017 Second Quarter Financial Results and Provides Business Update
Aug 7, 2017 • 7:05 am EDT Corbus Pharmaceuticals to Present New Data from Systemic Sclerosis Phase 2 Study of Anabasum at the 15th International Workshop on Scleroderma Research
Jun 15, 2017 • 7:05 am EDT Corbus Pharmaceuticals Presented Data from Phase 2 Study of Anabasum for the Treatment of Systemic Sclerosis at the EULAR 2017 Annual Meeting
Jun 8, 2017 • 9:10 am EDT Corbus Pharmaceuticals to Present Data from Phase 2 Study of Anabasum at the European Cystic Fibrosis Society 2017 Conference
Jun 1, 2017 • 7:30 am EDT Corbus Pharmaceuticals to Present at the 2017 Jefferies Global Healthcare Conference
May 11, 2017 • 8:00 am EDT Corbus Pharmaceuticals Announces Last Subject Enrolled in Phase 2 Study of Anabasum for the Treatment of Skin-Predominant Dermatomyositis
May 9, 2017 • 9:00 am EDT Corbus Pharmaceuticals Reports 2017 First Quarter Financial Results and Provides Business Update